Asia’s Most Trusted Brand in Nuclear Medicine Diagnostics

We are delighted to be honoured with the Award for ‘Asia's Most Trusted Brand in Nuclear Medicine Diagnostics' in the 1st Phase of the Brandscouncil Ratings Survey 2025. Awarded at the Brandscouncil Ratings International Conclave & Awards 2025, held on 21st March 2025 in Bangkok, TH, India-Thai Chamber of Commerce.

The award reflects our constant aspiration to excellence in our nuclear medicine diagnosis service and our ongoing strides to offer a superior, accurate, and reliable diagnosis service for our patients. Throughout the years, Molecular Diagnostics and Therapy has built a reputation as a trusted provider that utilises state-of-the-art technology and medical knowledge, along with a patient-focused approach, to provide unparalleled diagnostic solutions.

This distinction as one of the most trusted brands in Asia demonstrates patients’, healthcare professionals and partners' trust in our services. This success is the result of our commitment to delivering the highest level of quality, accuracy, and innovation in all our Truscan Healthcare actions, and trust is the basis of healthcare. 

We're constantly striving to use cutting-edge imaging technology and to offer advanced, specialised nuclear medicine options to help make our diagnostics more precise and to help improve your outcome.

The recognition is also a testament to the hard work, dedication, and talent of all of our staff, without whose contributions it would not be possible. We are always striving to be the leaders in diagnostic advancement and patient care with our drive toward excellence.

This is a major accomplishment at Molecular Diagnostics and Therapy, and this is our obligation as a healthcare organisation to strive for excellence even further. It will inspire us to invest more in technology, increase our quality standards,s and improve access to world-class diagnostic services.

Many thanks to our patients, our referring doctors, health care partners, and staff for their trust and support. It serves as a reminder to us of the importance of embracing our vision of Innovating Healthcare for the Future, making us seek continuous innovation in our services, increasing our accuracy, and reinforcing us as a trusted leader in the Asia region for nuclear medicine diagnostics services.